Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
出版年份 2023 全文链接
标题
Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-11-07
DOI
10.3389/fendo.2023.1254398
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom
- (2023) Hera Sandhu et al. ADVANCES IN THERAPY
- Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research
- (2023) Yan Xue et al. BMC PUBLIC HEALTH
- Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
- (2023) Marlene Chakhtoura et al. EClinicalMedicine
- Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery
- (2023) Michail Kokkorakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Topiramate (Topamax): Evolving Role in Weight Reduction Management: A Narrative Review
- (2023) Irza Wajid et al. Life-Basel
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
- (2022) Don Husereau et al. VALUE IN HEALTH
- EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model
- (2022) AV Olivieri et al. VALUE IN HEALTH
- Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
- (2021) Young Jin Tak et al. Current Obesity Reports
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Semaglutide for obesity: four STEPs forward, but more to come
- (2021) Donna H Ryan Lancet Diabetes & Endocrinology
- Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis
- (2021) Lin Zhang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Nonsurgical weight loss interventions: A systematic review of systematic reviews and meta‐analyses
- (2021) Laurie K. Twells et al. Obesity Reviews
- Epidemiology and determinants of obesity in China
- (2021) Xiong-Fei Pan et al. Lancet Diabetes & Endocrinology
- European Commission classifies obesity as a chronic disease
- (2021) Talha Burki Lancet Diabetes & Endocrinology
- Clinical management and treatment of obesity in China
- (2021) Qiang Zeng et al. Lancet Diabetes & Endocrinology
- The Most Undertreated Chronic Disease: Addressing Obesity in Primary Care Settings
- (2021) Shanna Tucker et al. Current Obesity Reports
- Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
- (2021) Angeliki M Angelidi et al. ENDOCRINE REVIEWS
- Wegovy (semaglutide): a new weight loss drug for chronic weight management
- (2021) Gurdeep Singh et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
- (2021) Qingyang Shi et al. LANCET
- Anti-obesity drug discovery: advances and challenges
- (2021) Timo D. Müller et al. NATURE REVIEWS DRUG DISCOVERY
- Prevalence of overweight and obesity in China: Results from a cross-sectional study of 441 thousand adults, 2012–2015
- (2020) Linfeng Zhang et al. Obesity Research & Clinical Practice
- Obesity in adults: a clinical practice guideline
- (2020) Sean Wharton et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis
- (2020) Romano Schneider et al. OBESITY SURGERY
- Nearly a decade on — trends, risk factors and policy implications in global obesity
- (2020) Vasanti S. Malik et al. Nature Reviews Endocrinology
- Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
- (2020) Barry M. Popkin et al. Obesity Reviews
- Decomposing adult obesity trends in China (1991–2011)
- (2019) Peng Nie et al. Economics & Human Biology
- Management of overweight and obesity in primary care—A systematic overview of international evidence‐based guidelines
- (2019) Thomas Semlitsch et al. Obesity Reviews
- Prevalence of Obesity and Associated Risk Factors and Cardiometabolic Comorbidities in Rural Northeast China
- (2019) Shiwen Yu et al. Biomed Research International
- Prevalence of overweight and obesity and associated risk factors among adult residents of northwest China: a cross-sectional study
- (2019) Ning Song et al. BMJ Open
- PDB14 COST-EFFECTIVENESS OF CONTRAVE® IN OBESITY MANAGEMENT IN CANADA
- (2019) M. Nuijten et al. VALUE IN HEALTH
- Prevalence and stabilizing trends in overweight and obesity among children and adolescents in China, 2011-2015
- (2018) Jiguo Zhang et al. BMC PUBLIC HEALTH
- Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
- (2018) Alison Avenell et al. HEALTH TECHNOLOGY ASSESSMENT
- Mechanisms, Pathophysiology, and Management of Obesity
- (2017) Steven B. Heymsfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- The lifetime costs of overweight and obesity in childhood and adolescence: a systematic review
- (2017) D. Hamilton et al. Obesity Reviews
- Pathways linking obesity to health-related quality of life
- (2017) Sangshin Park QUALITY OF LIFE RESEARCH
- Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland
- (2017) M Nuijten et al. VALUE IN HEALTH
- Economic Burden of Obesity: A Systematic Literature Review
- (2017) Maximilian Tremmel et al. International Journal of Environmental Research and Public Health
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of obesity
- (2016) George A Bray et al. LANCET
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- European Guidelines for Obesity Management in Adults
- (2015) Volkan Yumuk et al. Obesity Facts
- A systematic review of the cost-effectiveness of non-surgical obesity interventions in men
- (2015) Dwayne Boyers et al. Obesity Research & Clinical Practice
- Modeling the clinical and economic implications of obesity using microsimulation
- (2015) W. Su et al. JOURNAL OF MEDICAL ECONOMICS
- What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.
- (2014) R Ara et al. HEALTH TECHNOLOGY ASSESSMENT
- Reducing the global prevalence of overweight and obesity
- (2014) Klim McPherson LANCET
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Meta- and cost-effectiveness analysis of commercial weight loss strategies
- (2014) Eric A. Finkelstein et al. Obesity
- Cost-Effectiveness Analysis of Qsymia for Weight Loss
- (2014) Eric A. Finkelstein et al. PHARMACOECONOMICS
- The disproportionate economic burden associated with severe and complicated obesity: a systematic review
- (2013) E. Grieve et al. Obesity Reviews
- Global obesity: trends, risk factors and policy implications
- (2012) Vasanti S. Malik et al. Nature Reviews Endocrinology
- Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
- (2012) Andrew H. Briggs et al. VALUE IN HEALTH
- Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
- (2012) David M. Eddy et al. VALUE IN HEALTH
- Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
- (2011) J. Lennert Veerman et al. PLoS One
- Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review
- (2008) M Neovius et al. INTERNATIONAL JOURNAL OF OBESITY
- Cost-Effectiveness of a Low-Calorie Diet and Orlistat for Obese Persons: Modeling Long-Term Health Gains through Prevention of Obesity-Related Chronic Diseases
- (2008) Pieter H.M. van Baal et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now